In last trading session, Biohaven Ltd (NYSE:BHVN) saw 0.65 million shares changing hands with its beta currently measuring 3.88. Company’s recent per share price level of $29.15 trading at $0.93 or 3.30% at ring of the bell on the day assigns it a market valuation of $2.97B. That closing price of BHVN’s stock is at a discount of -107.41% from its 52-week high price of $60.46 and is indicating a premium of 8.06% from its 52-week low price of $26.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.52 million shares which gives us an average trading volume of 1.07 million if we extend that period to 3-months.
For Biohaven Ltd (BHVN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -1.49 in the current quarter.
Biohaven Ltd (NYSE:BHVN) trade information
Upright in the green during last session for gaining 3.30%, in the last five days BHVN remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $29.15 price level, adding 3.95% to its value on the day. Biohaven Ltd’s shares saw a change of -21.95% in year-to-date performance and have moved -2.38% in past 5-day. Biohaven Ltd (NYSE:BHVN) showed a performance of -30.79% in past 30-days. Number of shares sold short was 8.28 million shares which calculate 10.98 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 60 to the stock, which implies a rise of 51.42% to its current value. Analysts have been projecting 57 as a low price target for the stock while placing it at a high target of 65. It follows that stock’s current price would drop -95.54% in reaching the projected high whereas dropping to the targeted low would mean a loss of -95.54% for stock’s current value.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.39M for the same. And 9 analysts are in estimates of company making revenue of 1.39M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -49.78% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 26.73% while estimates for its earnings growth in next 5 years are of 23.01%.
Biohaven Ltd (NYSE:BHVN)’s Major holders
Insiders are in possession of 11.55% of company’s total shares while institution are holding 91.77 percent of that, with stock having share float percentage of 103.76%. Investors also watch the number of corporate investors in a company very closely, which is 91.77% institutions for Biohaven Ltd that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at BHVN for having 7.27 million shares of worth $252.41 million. And as of 2024-06-30, it was holding 8.9114 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 6.17 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.5608 of outstanding shares, having a total worth of $214.15 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.51 shares of worth $73.18 million or 2.46% of the total outstanding shares. The later fund manager was in possession of 2.31 shares on Dec 31, 2024 , making its stake of worth around $67.46 million in the company or a holder of 2.27% of company’s stock.
